表观遗传修饰：糖尿病防治新靶点
收稿日期: 2021-03-30
网络出版日期: 2022-07-25
基金资助
国家自然科学基金项目(81800756);江苏省中医药领军人才培养项目(SLJ0209)
韦晓, 孙烁烁, 陈国芳, 刘超 . 表观遗传修饰：糖尿病防治新靶点[J]. 内科理论与实践, 2021 , 16(06) : 422 -426 . DOI: 10.16138/j.1673-6087.2021.06.011
| [1] | Ling C, Rönn T. Epigenetics in human obesity and type 2 diabetes[J]. Cell Metab, 2019, 29(5): 1028-1044. |
| [2] | Feinberg AP. The key role of epigenetics in human disease prevention and mitigation[J]. N Engl J Med, 2018, 378(14): 1323-1334. |
| [3] | Kato M, Natarajan R. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory[J]. Nat Rev Nephrol, 2019, 15(6): 327-345. |
| [4] | Rosen ED, Kaestner KH, Natarajan R, et al. Epigenetics and epigenomics: implications for diabetes and obesity[J]. Diabetes, 2018, 67(10): 1923-1931. |
| [5] | Singh R, Chandel S, Dey D, et al. Epigenetic modification and therapeutic targets of diabetes mellitus[J]. Biosci Rep, 2020, 40(9): BSR20202160. |
| [6] | Greenberg MVC, Bourc'his D. The diverse roles of DNA methylation in mammalian development and disease[J]. Nat Rev Mol Cell Biol, 2019, 20(10): 590-607. |
| [7] | Johnson ND, Conneely KN. The role of DNA methylation and hydroxymethylation in immunosenescence[J]. Ageing Res Rev, 2019, 51: 11-23. |
| [8] | Xu GL, Bochtler M. Reversal of nucleobase methylation by dioxygenases[J]. Nat Chem Biol, 2020, 16(11): 1160-1169. |
| [9] | Wahl S, Drong A, Lehne B, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity[J]. Nature, 2017, 541(7635): 81-86. |
| [10] | Chambers JC, Loh M, Lehne B, et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study[J]. Lancet Diabetes Endocrinol, 2015, 3(7): 526-534. |
| [11] | Paul DS, Teschendorff AE, Dang MA, et al. Increased DNA methylation variability in type 1 diabetes across three immune effector cell types[J]. Nat Commun, 2016, 7: 13555. |
| [12] | Hjort L, Martino D, Grunnet LG, et al. Gestational diabetes and maternal obesity are associated with epigenome-wide methylation changes in children[J] JCI Insight, 2018, 3(17): e122572. |
| [13] | Stricker SH, Köferle A, Beck S. From profiles to function in epigenomics[J]. Nat Rev Genet, 2017, 18(1): 51-66. |
| [14] | Bates SE. Epigenetic therapies for cancer[J]. N Engl J Med, 2020, 383(7): 650-663. |
| [15] | Gao M, Deng XL, Liu ZH, et al. Liraglutide protects β-cell function by reversing histone modification of Pdx-1 proximal promoter in catch-up growth male rats[J]. J Diabetes Complications, 2018, 32(11): 985-994. |
| [16] | Zhao L, Zhang F, Ding X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes[J]. Science, 2018, 359(6380): 1151-1156. |
| [17] | Zhong Q, Kowluru RA. Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon[J]. J Cell Biochem, 2010, 110(6): 1306-1313. |
| [18] | Hong S, Zhou W, Fang B, et al. Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion[J]. Nat Med, 2017, 23(2): 223-234. |
| [19] | Asif S, Morrow NM, Mulvihill EE, et al. Understanding dietary intervention-mediated epigenetic modifications in metabolic diseases[J]. Front Genet, 2020, 11: 590369. |
| [20] | Calderon D, Nguyen MLT, Mezger A, et al. Landscape of stimulation-responsive chromatin across diverse human immune cells[J]. Nat Genet, 2019, 51(10): 1494-1505. |
| [21] | Wei Z, Yoshihara E, He N, et al. Vitamin D switches BAF complexes to protect β cells[J]. Cell, 2018, 173(5): 1135-1149. |
| [22] | Local A, Huang H, Albuquerque CP, et al. Identification of H3K4me1-associated proteins at mammalian enhancers[J]. Nat Genet, 2018, 50(1): 73-82. |
| [23] | Batista TM, Jayavelu AK, Wewer Albrechtsen NJ, et al. A cell-autonomous signature of dysregulated protein phosphorylation underlies muscle insulin resistance in type 2 diabetes[J]. Cell Metab, 2020, 32(5): 844-859. |
| [24] | Skvortsova K, Iovino N, Bogdanoviéc O. Functions and mechanisms of epigenetic inheritance in animals[J]. Nat Rev Mol Cell Biol, 2018, 19(12): 774-790. |
| [25] | Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific microRNA regulates insulin secretion[J]. Nature, 2004, 432(7014): 226-230. |
| [26] | Al-Muhtaresh HA, Al-Kafaji G. Evaluation of two-diabetes related microRNAs suitability as earlier blood biomarkers for detecting prediabetes and type 2 diabetes mellitus[J]. J Clin Med, 2018, 7(2): 12. |
| [27] | López-Beas J, Capilla-González V, Aguilera Y, et al. miR-7 modulates hESC differentiation into insulin-producing beta-like cells and contributes to cell maturation[J]. Mol Ther Nucleic Acids, 2018, 12: 463-477. |
| [28] | Belgardt BF, Ahmed K, Spranger M, et al. The micro-RNA-200 family regulates pancreatic beta cell survival in type 2 diabetes[J]. Nat Med, 2015, 21(6): 619-627. |
| [29] | Huang Q, You W, Li Y, et al. Glucolipotoxicity-inhibited miR-299-5p regulates pancreatic β-cell function and survival[J]. Diabetes, 2018, 67(11): 2280-2292. |
| [30] | Sui M, Chen G, Mao X, et al. Gegen qinlian decoction ameliorates hepatic insulin resistance by silent information regulator1 (SIRT1)-dependent deacetylation of forkhead box O1(FOXO1)[J]. Med Sci Monit, 2019, 25: 8544-8553. |
| [31] | Long J, Wang Y, Wang W, et al. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy[J]. J Biol Chem, 2011, 286(13): 11837-11848. |
| [32] | Guo Z, Cao Q, Zhao Z, et al. Biogenesis, features, functions, and disease relationships of a specific circular RNA: CDR1as[J]. Aging Dis, 2020, 11(4): 1009-1020. |
| [33] | Shi R, Chen Y, Liao Y, et al. Research status of differentially expressed noncoding RNAs in type 2 diabetes patients[J]. Biomed Res Int, 2020, 2020: 3816056. |
| [34] | Akerman I, Tu Z, Beucher A, et al. Human pancreatic β cell lncRNAs control cell-specific regulatory networks[J]. Cell Metab, 2017, 25(2): 400-411. |
| [35] | Roundtree IA, Evans ME, Pan T, et al. Dynamic RNA modifications in gene expression regulation[J]. Cell, 2017, 169(7): 1187-1200. |
| [36] | Wang Y, Sun J, Lin Z, et al. m6A mRNA methylation controls functional maturation in neonatal murine β-cells[J]. Diabetes, 2020, 69(8): 1708-1722. |
| [37] | Li X, Jiang Y, Sun X, et al. METTL3 is required for maintaining β-cell function[J]. Metabolism, 2021, 116: 154702. |
| [38] | Li Y, Zhang Q, Cui G, et al. m6A regulates liver metabolic disorders and hepatogenous diabetes[J]. Genomics Proteomics Bioinformatics, 2020, 18(4): 371-383. |
| [39] | Cencioni C, Spallotta F, Greco S, et al. Epigenetic mechanisms of hyperglycemic memory[J]. Int J Biochem Cell Biol, 2014, 51: 155-158. |
| [40] | Trajkovski M, Hausser J, Soutschek J, et al. MicroRNAs 103 and 107 regulate insulin sensitivity[J]. Nature, 2011, 474(7353): 649-653. |
| [41] | Shen W, Tremblay MS, Deshmukh VA, et al. Small-molecule inducer of β cell proliferation identified by high-throughput screening[J]. J Am Chem Soc, 2013, 135(5): 1669-1672. |
| [42] | Song MY, Kim EK, Moon WS, et al. Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-κB pathway[J]. Toxicol Appl Pharmacol, 2009, 235(1): 57-67. |
| [43] | Liu X, Liu J, Xiao W, et al. SIRT1 Regulates N6-methyladenosine RNA modification in hepatocarcinogenesis by inducing RANBP2-dependent FTO SUMOylation[J]. Hepatology, 2020, 72(6): 2029-2050. |
/
| 〈 |
|
〉 |
